Postdoctoral Fellow in @florian_krammer lab at @IcahnMountSinai working on #SARSCoV2 and #Influenza #Vaccines PhD with @PrNickGay @Cambridge_uni on #Ebola
New York CIty
Joined May 2019
- Tweets316
- Following383
- Followers87
- Likes398
Michael Scherm retweeted
Latest US #SARSCoV2 genomics shows continued XBB.1.16 growth advantage vs XBB.1.5 variant
covid.cdc.gov/covid-data-tra… with new booster (September) expected to be monovalent XBB.1.5
Michael Scherm retweeted
If you don't get it, you don't get it
Download our (updated) massive database of POSTDOC fellowships.
We list 373 fellowships w/ description, $ amount, deadline, and eligibility criteria (e.g. citizenship).
HERE: research.jhu.edu/rdt/funding…
Michael Scherm retweeted
Chinese Censorship Is Quietly Rewriting the Covid-19 Story
Under government pressure, Chinese scientists have retracted studies and withheld or deleted data.
#MyGiftArticle
@MaraHvistendahl and @benjmueller report @nytimes
nytimes.com/2023/04/23/world…
Michael Scherm retweeted
⚠️ BREAKING:
Mystery disease kills three people in 3 days in Burundi 🇧🇮
According to witnesses on the spot, "the symptoms include abdominal pain, nasal bleeding which increases after death, acute headaches, high fever, vomiting and dizziness".
ALT An Ebola victim is buried in a Muslim cemetery in the city of Beni, in the Democratic Republic of the Congo.Photograph by Jerome Delay / AP
Michael Scherm retweeted
We went on a short lab excursion today to see Flaco in Central Park. And got lucky.
Picture credits: Robert Hoelzl and Temima Yellin.
Michael Scherm retweeted
A very interesting paper from Dr. Mark Davis’ group shows that in response to the mRNA vaccine, CD8 T cell responses are attenuated in people who had prior COVID compared to uninfected people. What does this mean? (1/)
doi.org/10.1016/j.immuni.202…
Michael Scherm retweeted
As I reflect today on #InternationalLongCovidAwarenessDay I know that there is a lot of suffering, loss and grief to account for, but I wanted to offer a message of hope. Today, we:
1) Categorically know more about #LongCovid than we did last year
2) Have educated thousands of 1/
Michael Scherm retweeted
How are chromatin marks maintained across DNA replication? 🧬A beautiful study by @ValeFlury @GrothLab now out @CellCellPress uncovers that modified H2A-2B histones are recycled and help restoring chromatin mods on H3-H4!
#NotThecover, but very chuffed with this one!
#sciart 🧵
ALT Journal cover inspired by Escher's The drawing hands. Two old wrinkled hands emerge from a nucleosome and write chromatin modifications on the other histones
Michael Scherm retweeted
Johnson & Johnson stops development of all antibacterial programs. Sigh!
J&J developed Levaquin, bedaquiline, and several other life-saving antibiotics.
Obviously this happens because they can't make money on antibiotics. Thi…lnkd.in/eSQgfX-t lnkd.in/eK-3RuP4
Michael Scherm retweeted
“We’re very early,' @PutrinoLab says.. But every sample from #LongCovid patients has revealed #MicroClots."
"They are not capable of clogging large vessels.. but they can significantly affect organ function."
nationalgeographic.com/magaz…
Michael Scherm retweeted
This is amazing to be able to test for 4 different viruses in a single, low-cost, in-home rapid test. This type of technology should be accelerated for review. The impact on early, appropriate treatment & breaking transmission could be remarkable.
Influenza A positive test result.
Test 4 respiratory infections at the same time with the combo #Fluorecare test. Available @Measie_ : measie.com/product/4-in-1-co…
Michael Scherm retweeted
“I’ll have a civet steak, medium rare, with a side of SARS-CoV-3, please” theguardian.com/environment/…
Michael Scherm retweeted
Today’s entry for “study that broke my brain”:
jci.org/articles/view/44876
Apparently when sooty mangabeys get SIV they just function normally(?) with double negative T cells.
Michael Scherm retweeted
"Compelling evidence for the role of carboxylic acid in guiding the mosquito's preference toward specific people"
cell.com/cell/fulltext/S0092… @CellCellPress
Michael Scherm retweeted
Very excited that my PhD research is in The Guardian 😄 read about our paper here 👇
theguardian.com/science/2022…
Michael Scherm retweeted
1) Boston University researches have made a SARS-CoV-2 virus that has the spike of Omicron BA.1 and the remaining genome of the ancestral SARS-CoV-2. Now they got in trouble because this research was funded by the US government (NIH) but they did not ask the NIH...
Michael Scherm retweeted
Not the smartest launch of a preprint.....A paper going viral, showing massive increase in virulence of SARS COV 2 in mice when combining Omicron spike with the backbone of the ancestral strain with D614G. Screaming headlines about this. What the headlines do not show:
Michael Scherm retweeted
Grateful for the opportunity to coauthor this review with the incredible @michelle_monje 🙏🏼 We discuss pathobiology of #longCOVID in the central nervous system and speculate on chief mechanisms that contribute to this emerging neurological health crisis.
cell.com/neuron/fulltext/S08…
Michael Scherm retweeted
New and encouraging @NatureMedicine on bivalent Beta booster
"These results indicate that bivalent booster vaccines can induce potent, durable and broad antibody responses against multiple variants, providing a new tool in response to emerging variants"
nature.com/articles/s41591-0…
Michael Scherm retweeted
Here is how WHO and partners are responding to the current #Ebola outbreak. 🧵
📌Sending additional specialists, supplies, & resources to curb the spread of the infection.
